7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Splenic red pulp macrophages (RPMs) contribute to erythrocyte homeostasis and are required for iron recycling. Heme induces the expression of SPIC transcription factor in monocyte-derived macrophages and promotes their differentiation into RPM precursors, pre-RPMs. However, the requirements for differentiation into mature RPMs remain unknown. Here, we have demonstrated that interleukin (IL)-33 associated with erythrocytes and co-cooperated with heme to promote the generation of mature RPMs through activation of the MyD88 adaptor protein and ERK1/2 kinases downstream of the IL-33 receptor, IL1RL1. IL-33- and IL1RL1-deficient mice showed defective iron recycling and increased splenic iron deposition. Gene expression and chromatin accessibility studies revealed a role for GATA transcription factors downstream of IL-33 signaling during the development of pre-RPMs that retained full potential to differentiate into RPMs. Thus, IL-33 instructs the development of RPMs as a response to physiological erythrocyte damage with important implications to iron recycling and iron homeostasis.

          Graphical Abstract

          Highlights

          • IL-33 signaling promotes development of monocyte-derived red pulp macrophages (RPMs)

          • Il33 −/− and Il1rl1 −/− mice have decreased RPMs and splenic erythrophagocytosis

          • ERK activation is required for RPM development and is potentiated by hemin and IL-33

          • GATA2 instructs RPM development and is aberrant in Il1rl1 −/− RPM precursors

          Abstract

          Splenic red pulp macrophages (RPMs) are critical for iron recycling. Here, Lu et al. implicate a role for IL-33 signaling in the regulation of GATA2, which controls the transition of monocytes to produce pre-RPMs that are competent to terminally differentiate into mature RPMs.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation.

          A defining feature of inflammation is the accumulation of innate immune cells in the tissue that are thought to be recruited from the blood. We reveal that a distinct process exists in which tissue macrophages undergo rapid in situ proliferation in order to increase population density. This inflammatory mechanism occurred during T helper 2 (T(H)2)-related pathologies under the control of the archetypal T(H)2 cytokine interleukin-4 (IL-4) and was a fundamental component of T(H)2 inflammation because exogenous IL-4 was sufficient to drive accumulation of tissue macrophages through self-renewal. Thus, expansion of innate cells necessary for pathogen control or wound repair can occur without recruitment of potentially tissue-destructive inflammatory cells.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages.

            Splenic red pulp macrophages (RPM) degrade senescent erythrocytes and recycle heme-associated iron. The transcription factor SPI-C is selectively expressed by RPM and is required for their development, but the physiologic stimulus inducing Spic is unknown. Here, we report that Spic also regulated the development of F4/80(+)VCAM1(+) bone marrow macrophages (BMM) and that Spic expression in BMM and RPM development was induced by heme, a metabolite of erythrocyte degradation. Pathologic hemolysis induced loss of RPM and BMM due to excess heme but induced Spic in monocytes to generate new RPM and BMM. Spic expression in monocytes was constitutively inhibited by the transcriptional repressor BACH1. Heme induced proteasome-dependent BACH1 degradation and rapid Spic derepression. Furthermore, cysteine-proline dipeptide motifs in BACH1 that mediate heme-dependent degradation were necessary for Spic induction by heme. These findings are the first example of metabolite-driven differentiation of a tissue-resident macrophage subset and provide new insights into iron homeostasis. Copyright © 2014 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

              Cigarette smoking is a major risk factor for chronic obstructive pulmonary disease and is presumed to be central to the altered responsiveness to recurrent infection in these patients. We examined the effects of smoke priming underlying the exacerbated response to viral infection in mice. Lack of interleukin-33 (IL-33) signaling conferred complete protection during exacerbation and prevented enhanced inflammation and exaggerated weight loss. Mechanistically, smoke was required to upregulate epithelial-derived IL-33 and simultaneously alter the distribution of the IL-33 receptor ST2. Specifically, smoke decreased ST2 expression on group 2 innate lymphoid cells (ILC2s) while elevating ST2 expression on macrophages and natural killer (NK) cells, thus altering IL-33 responsiveness within the lung. Consequently, upon infection and release, increased local IL-33 significantly amplified type I proinflammatory responses via synergistic modulation of macrophage and NK cell function. Therefore, in COPD, smoke alters the lung microenvironment to facilitate an alternative IL-33-dependent exaggerated proinflammatory response to infection, exacerbating disease.
                Bookmark

                Author and article information

                Contributors
                Journal
                Immunity
                Immunity
                Immunity
                Cell Press
                1074-7613
                1097-4180
                19 May 2020
                19 May 2020
                : 52
                : 5
                : 782-793.e5
                Affiliations
                [1 ]Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK
                [2 ]Translational Sciences and Experimental Medicine, Early Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK
                [3 ]The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories, Cambridge, UK
                [4 ]Department of Veterinary Medicine, University of Cambridge, Cambridge, UK
                [5 ]Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
                [6 ]Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
                [7 ]Department of Pathology, Oslo University Hospital Rikshospitalet, Norway
                [8 ]Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland
                [9 ]Department of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland
                [10 ]School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland
                [11 ]Bioscience Asthma, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
                [12 ]Institut National de la Santé et de la Recherche Médicale, Paris Cardiovascular Research Center, Paris, France
                Author notes
                []Corresponding author zm255@ 123456medschl.cam.ac.uk
                [13]

                Lead Contact

                Article
                S1074-7613(20)30119-9
                10.1016/j.immuni.2020.03.006
                7237885
                32272082
                18919bf8-2d6b-4f55-9588-17d268bd2d6f
                © 2020 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 25 September 2018
                : 31 January 2020
                : 13 March 2020
                Categories
                Article

                Immunology
                interleukins,red pulp macrophage,iron metabolism,erythrophagocytosis,interleukin-33,interleukin-33 receptor

                Comments

                Comment on this article